Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.79
-0.14 (-2.02%)
Jul 16, 2025, 11:22 AM - Market open
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$1,072,667
Profits / Employee
-$146,222
Market Cap
368.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EBS News
- 1 day ago - Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 7 days ago - Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts - GlobeNewsWire
- 13 days ago - Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate - GlobeNewsWire
- 23 days ago - Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply - GlobeNewsWire
- 25 days ago - Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful - Seeking Alpha
- 26 days ago - Emergent BioSolutions Announces Addition to Russell 3000® Index - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies - GlobeNewsWire
- 2 months ago - Emergent BioSolutions to Participate in Upcoming Investor Conferences - GlobeNewsWire